The effect of Tenecteplase on intravenous thrombus and retinal blood flow in patients with branch retinal vein occlusion (BRVO).

Trial Profile

The effect of Tenecteplase on intravenous thrombus and retinal blood flow in patients with branch retinal vein occlusion (BRVO).

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Mar 2017

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Branch retinal vein occlusion
  • Focus Therapeutic Use
  • Acronyms T-BRVO
  • Most Recent Events

    • 08 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 18 Jun 2015 Planned initiation date changed from 1 Apr 2015 to 1 Jul 2015 as per Australian New Zealand Clinical Trials Registry record.
    • 05 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top